Cargando…
Regulator of oligodendrocyte maturation, miR-219, a potential biomarker for MS
BACKGROUND: Multiple sclerosis (MS) is a demyelinating and degenerative disease of the central nervous system. Normally, demyelination is followed by remyelination, which requires repopulation of a demyelinated area by oligodendrocyte precursor cells. Although large numbers of precursor cells are pr...
Autores principales: | Bruinsma, Ilona B., van Dijk, Marie, Bridel, Claire, van de Lisdonk, Timothy, Haverkort, Sanne Q., Runia, Tessel F., Steinman, Lawrence, Hintzen, Rogier Q., Killestein, Joep, Verbeek, Marcel M., Teunissen, Charlotte E., de Jong, Brigit A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716023/ https://www.ncbi.nlm.nih.gov/pubmed/29202778 http://dx.doi.org/10.1186/s12974-017-1006-3 |
Ejemplares similares
-
Smoking at time of CIS increases the risk of clinically definite multiple sclerosis
por: van der Vuurst de Vries, Roos M., et al.
Publicado: (2018) -
Fatigue after a first attack of suspected multiple
sclerosis
por: van der Vuurst de Vries, Roos M, et al.
Publicado: (2017) -
Regulation of miRNA 219 and miRNA Clusters 338 and 17-92 in Oligodendrocytes
por: de Faria Jr., Omar, et al.
Publicado: (2012) -
No Plasmatic Proteomic Signature at Clinical Disease Onset Associated With 11 Year Clinical, Cognitive and MRI Outcomes in Relapsing-Remitting Multiple Sclerosis Patients
por: Bridel, Claire, et al.
Publicado: (2018) -
Emerging safety issues in alemtuzumab-treated MS
patients
por: Killestein, Joep, et al.
Publicado: (2019)